Literature DB >> 15315355

Expression of CC chemokine ligand 20 and CC chemokine receptor 6 mRNA in patients with psoriasis vulgaris.

Yan Wu1, Jiawen Li.   

Abstract

In order to explore the possible role of CC chemokine ligand 20 (CCL20) and its receptor CC chemokine receptor 6 (CCR6) in the pathogenesis of psoriasis, the expression levels of mRNA of them in psoriatic lesions were investigated. The skin biopsies were collected from skin lesions in 35 cases of psoriasis vulgaris and 18 normal controls. RT-PCR was used to semi-quantitatively analyze the mRNA expression of CCL20 and CCR6 in the psoriatic lesions and the normal skin tissues. The results showed that the mRNA of CCL20 and CCR6 was present in every specimen. The expression levels of CCL20 mRNA in skin lesions were 1.1397 +/- 0.0521, which were greatly higher than those in normal controls (0.8681 +/- 0.0308) (P<0.001). The expression levels of CCR6 mRNA in skin lesions were 1.1103 +/- 0.0538, significantly higher than in the controls (0.9131 +/- 0.0433, P<0.001). These findings indicate that up-regulated expression of CCL20 and CCR6 mRNA might be related to the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315355     DOI: 10.1007/bf02832019

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

1.  Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta.

Authors:  D L Rossi; A P Vicari; K Franz-Bacon; T K McClanahan; A Zlotnik
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

Review 2.  Animal models of psoriasis - what can we learn from them?

Authors:  M P Schön
Journal:  J Invest Dermatol       Date:  1999-04       Impact factor: 8.551

3.  Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines.

Authors:  M Chabaud; G Page; P Miossec
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

4.  Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.

Authors:  B Homey; M C Dieu-Nosjean; A Wiesenborn; C Massacrier; J J Pin; E Oldham; D Catron; M E Buchanan; A Müller; R deWaal Malefyt; G Deng; R Orozco; T Ruzicka; P Lehmann; S Lebecque; C Caux; A Zlotnik
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

5.  Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.

Authors:  C Albanesi; C Scarponi; A Cavani; M Federici; F Nasorri; G Girolomoni
Journal:  J Invest Dermatol       Date:  2000-07       Impact factor: 8.551

6.  Localization of monocyte chemotactic and activating factor (MCAF/MCP-1) in psoriasis.

Authors:  M Deleuran; L Buhl; T Ellingsen; A Harada; C G Larsen; K Matsushima; B Deleuran
Journal:  J Dermatol Sci       Date:  1996-12       Impact factor: 4.563

7.  Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans.

Authors:  Y Tanaka; T Imai; M Baba; I Ishikawa; M Uehira; H Nomiyama; O Yoshie
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

8.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.

Authors:  K Uyemura; M Yamamura; D F Fivenson; R L Modlin; B J Nickoloff
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

9.  Increased spontaneous production of IL-8 in peripheral blood monocytes from the psoriatic patient: relation to focal infection and response to treatments.

Authors:  Y Teranishi; H Mizutani; M Murata; M Shimizu; K Matsushima
Journal:  J Dermatol Sci       Date:  1995-07       Impact factor: 4.563

10.  Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors.

Authors:  M C Dieu-Nosjean; C Massacrier; B Homey; B Vanbervliet; J J Pin; A Vicari; S Lebecque; C Dezutter-Dambuyant; D Schmitt; A Zlotnik; C Caux
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

  10 in total
  2 in total

1.  Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris.

Authors:  T Yoshizaki; N Bandoh; S Ueda; H Nozawa; T Goto; K Kishibe; M Takahara; Y Harabuchi
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

2.  Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.

Authors:  A E Getschman; Y Imai; O Larsen; F C Peterson; X Wu; M M Rosenkilde; S T Hwang; B F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.